CRISM Therapeutics (CRTX) Stock Chart & Stock Price History GBX 10.55 -0.20 (-1.86%) As of 08/6/2025 10:48 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsBuy This Stock CRISM Therapeutics Stock Price Performance The CRISM Therapeutics (CRTX) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 5.50%. In the past month, the stock has increased 0.48%, reflecting recent market activity. As of the latest close, CRISM Therapeutics traded at GBX 10.55 with a market cap of £1.15 million and volume of 985 shares. Receive CRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CRISM Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.19%1 Month Performance+0.48%3 Month Performance-38.52%Year-To-Date Performance+5.50% CRTX Stock Chart for Thursday, August, 7, 2025 CRTX Chart by TradingView CRISM Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/06/2025GBX 10.79GBX 10.55-2.22%GBX 10.75GBX 10.55985 shs£1.15 million08/05/2025GBX 10.50GBX 10.79+2.76%GBX 10.79GBX 10.5010,125 shs£1.18 million08/04/2025GBX 10.57GBX 10.50-0.66%GBX 10.75GBX 10.50303 shs£1.14 million08/01/2025GBX 10.57GBX 10.57GBX 11GBX 10.577,486 shs£1.15 million07/31/2025GBX 10.50GBX 10.57+0.67%GBX 10.83GBX 10.5711,218 shs£1.15 million07/30/2025GBX 10.51GBX 10.50-0.05%GBX 10.75GBX 10.50125 shs£1.14 million07/29/2025GBX 10.50GBX 10.51+0.05%GBX 10.95GBX 10.5110,644 shs£1.14 million07/28/2025GBX 10.87GBX 10.50-3.40%GBX 10.87GBX 10.5032,906 shs£1.14 million07/25/2025GBX 11.25GBX 10.87-3.38%GBX 11GBX 10.50108,311 shs£1.18 million07/24/2025GBX 10.55GBX 11.25+6.64%GBX 11.25GBX 10.5050,418 shs£1.23 million Get the Latest News and Ratings for CRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CRISM Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/23/2025GBX 10.83GBX 10.55-2.59%GBX 11.25GBX 10.55310,370 shs£1.15 million07/22/2025GBX 10.83GBX 10.83GBX 11.62GBX 10.8319,465 shs£1.18 million07/21/2025GBX 11.55GBX 10.83-6.23%GBX 11.62GBX 10.8319,465 shs£1.18 million07/18/2025GBX 11.59GBX 11.55-0.35%GBX 11.55GBX 10.7572,867 shs£1.26 million07/17/2025GBX 11.59GBX 11.59GBX 11.60GBX 10.5022,834 shs£1.26 million07/16/2025GBX 10.80GBX 11.59+7.31%GBX 11.60GBX 10.5022,834 shs£1.26 million07/15/2025GBX 10.75GBX 10.80+0.47%GBX 11.62GBX 10.509,771 shs£1.18 million07/14/2025GBX 11.67GBX 10.75-7.88%GBX 11.65GBX 10.7515,725 shs£1.17 million07/11/2025GBX 11.67GBX 11.67GBX 12GBX 10.7560,950 shs£1.27 million07/10/2025GBX 11.67GBX 11.67GBX 11.67GBX 11.25214 shs£1.27 million07/09/2025GBX 10.75GBX 11.67+8.56%GBX 12GBX 11.2536,572 shs£1.27 million07/08/2025GBX 10.50GBX 10.75+2.38%GBX 11.70GBX 10.755,902 shs£1.17 million07/07/2025GBX 11GBX 10.50-4.55%GBX 11.20GBX 10933,000 shs£1.14 million Related Companies Aterian Stock Price Chart Anglesey Mining Stock Price Chart Beowulf Mining Stock Price Chart Firering Strategic Minerals Stock Price Chart PYX Resources Stock Price Chart African Pioneer Stock Price Chart Altona Rare Earths Stock Price Chart Thor Energy Stock Price Chart Shuka Minerals Stock Price Chart Europa Metals Stock Price Chart Receive CRTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CRISM Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:CRTX) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISM Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISM Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
